Compare IDEXX Laboratories, Inc. (IDXX) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Utilities Select Sector SPDR Fund — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Utilities Select Sector SPDR Fund trades at $41.39 (market cap $23.60B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Utilities Select Sector SPDR Fund is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| IDXX | XLU | |
|---|---|---|
Market Cap | $40.43B | $23.60B |
Volume | 692,164 | 28,758,237 |
Sector | Health | — |
52-Week High | $766.68 | $47.73 |
52-Week Low | $504.70 | $39.25 |
Typical Hold Time | 46 Days | 80 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
XLU trades at $41.07, down 0.19% on the day, as utility stocks face pressure from rising interest rates. The ETF recently hit 52-week lows amid sector-wide selling, though technical indicators show a mixed picture with bullish moving averages but neutral oscillators. Recent news highlights oversold conditions in utilities, with the sector experiencing its steepest monthly drop in nearly two years according to 24/7 Wall Street (2026-10-02).
The outlook remains challenged by interest rate sensitivity, but defensive characteristics could provide support if economic uncertainty persists. Key risks include continued rate hikes and regulatory headwinds, while potential catalysts include defensive rotation during market volatility and AI-driven power demand growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
